ALGN
Align Technology, Inc.NASDAQHealthcare$170.60-1.23%OpenMarket Cap: $12.24B
As of 2026-04-06
Valuation
P/E (TTM)
29.83
PEG
—
P/B
3.02
P/S
3.03
EV/EBITDA
13.94
DCF Value
$84.21
FCF Yield
4.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
67.3%
Operating Margin
13.6%
Net Margin
10.2%
ROE
10.4%
ROA
7.3%
ROIC
8.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $1.05B | 65.7% | $159.6M | $135.8M | $1.89 | — |
| FY 2025 | $4.03B | 68.3% | $616.2M | $410.4M | $5.65 | — |
| Q3 2025 | $995.7M | 64.2% | $96.3M | $56.8M | $0.78 | — |
| Q2 2025 | $1.01B | 69.9% | $163.0M | $124.6M | $1.72 | — |
| Q1 2025 | $979.3M | 69.5% | $131.1M | $93.2M | $1.27 | — |
| Q4 2024 | $995.2M | 70.0% | $144.1M | $103.8M | $1.39 | — |
| FY 2024 | $4.00B | 70.0% | $607.6M | $421.4M | $5.62 | — |
| Q3 2024 | $977.9M | 69.7% | $162.3M | $116.0M | $1.55 | — |
| Q2 2024 | $1.03B | 70.3% | $147.0M | $96.6M | $1.28 | — |
| Q1 2024 | $997.4M | 70.0% | $154.1M | $105.0M | $1.39 | — |
| Q4 2023 | $956.7M | 70.0% | $171.5M | $124.0M | $1.64 | — |
| FY 2023 | $3.86B | 70.1% | $643.3M | $445.1M | $5.81 | — |